Medical News

RSS

ATS CryoMaze Probe receives CE Mark

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the receipt of CE Mark for the ATS CryoMaze® 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.

14 Oct 2009

NASA signs patent license agreement with OxyHeal Medical Systems for hyperbaric chamber technology

NASA has signed a patent license agreement with a California company to improve the medical community's access to hyperbaric chambers used to treat many medical conditions and emergencies. OxyHeal Medical Systems Inc. of National City, Calif., will develop new products based on technologies NASA originally developed for space.

14 Oct 2009

TAXIS Pharmaceuticals, Rutgers and UMDNJ to develop and commercialize a novel antimicrobial technology

TAXIS Pharmaceuticals, Inc. (TAXIS), Rutgers, The State University of New Jersey, and the University of Medicine and Dentistry of New Jersey (UMDNJ) have entered into an exclusive licensing agreement for worldwide rights to develop and commercialize a novel antimicrobial technology addressing multidrug-resistant (MDR) bacterial infections.

14 Oct 2009

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Mention the words "bubble boy" and many will recall David Vetter, the kid with big eyes and a thick thatch of dark hair who died 25 years ago after spending almost the entire 12 years of his life in a germ-free, plastic bubble. David was born with severe combined immune deficiency, or SCID, a condition that robbed him of an immune system.

14 Oct 2009

Researchers discover new cancer gene that causes adenoid cystic carcinoma

The cancer caused by this new cancer gene is called adenoid cystic carcinoma and is a slow-growing but deadly form of cancer. The research group can now show that the gene is found in 100% of these tumours, which means that a genetic test can easily be used to make a correct diagnosis.

14 Oct 2009

International Stem Cell launches human cell culture products into commercial research markets

International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human “parthenogenetic” stem cells from unfertilized eggs.

14 Oct 2009

As Canadian population ages, blood donors dwindle

The Canadian blood supply relies heavily on a small number of donors-with young adults donating at higher rates-which may prove problematic as the population ages, according to a new study from McMaster University.

14 Oct 2009

Physicians having less than six hours of sleep linked to increase rate of surgical complications

Attending surgeons and obstetricians/gynecologists who worked nighttime hours did not have a significantly greater rate of complications for procedures performed the next day, but having less than six hours of opportunity for sleep between procedures was associated with an increased rate of surgical complications, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

UC Irvine implements automated perioperative solution from Surgical Information Systems

University of California, Irvine Medical Center has used an automated perioperative solution from Surgical Information Systems (SIS) to increase operating room efficiencies, improving quality assurance, enhancing billing revenue and improving compliance.

14 Oct 2009

Swedish Risk Drinking Project surveys physicians and nurses of Sweden

The proportion of health care personnel reporting that they always or often queried their patients regarding alcohol use has increased significantly. This is particularly notable with nurses, where the proportion has doubled to 60 per cent, and midwives, where 92 per cent estimate their capacity to identify risk consumption as good or very good.

14 Oct 2009

NetMotion Wireless publishes free mobile computing white paper for healthcare IT managers

In a recent survey of healthcare IT decision makers, 80 percent reported that mobility initiatives were more important to their organizations than they were a year ago.

14 Oct 2009

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

According to a new report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $12.8 billion in 2008 to $17.8 billion by 2014.

14 Oct 2009

New diagnostic technology to detect breast cancer

"We were ready to start a family when a mammogram revealed an abnormal mass in my left breast," said Staci Sansolo, 34, of New Jersey. A biopsy revealed the mass was not cancer, but a second-round test found another area of concern.

14 Oct 2009

Research reveals the genetic basis of DispersinB enzyme substrate based biofilm formation in bacteria

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse bacterial biofilms is pleased to announce that a recent research publication from Princeton University reveals the genetic basis of poly-ß-1,6-N-acetylglucosamine (PNAG), the DispersinB® enzyme substrate, based biofilm formation in bacteria.

14 Oct 2009

Is DDT pesticide safe to combat malaria?

Malaria risk threatens the life and health of thousands daily. In high-risk areas, including sub-Saharan Africa, malaria-related deaths happen every thirty seconds.

14 Oct 2009

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.

14 Oct 2009

NTU condemns Senate Finance Committee's support for health care bill

The 362,000-member National Taxpayers Union (NTU) today condemned the Senate Finance Committee's 14-9 vote to support the health care bill drafted by Senator Max Baucus (D-MT), pointing to hundreds of billions of dollars in damaging tax increases. This so-called "moderate" health care reform bill would grow the already bloated federal budget while saddling middle class families with billions in new taxes.

14 Oct 2009

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.

14 Oct 2009

New UCL cancer research centre launched in UK

A new centre is launched in London today (Wednesday), joining a select group of Cancer Research UK Centres across the UK.

14 Oct 2009

FDA recommends approval for UI Pharmaceuticals to manufacture an aseptically filled sterile drug product

In September 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture and test an aseptically filled, sterile prescription drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into vials.

14 Oct 2009

Medical News

ATS CryoMaze Probe receives CE Mark

NASA signs patent license agreement with OxyHeal Medical Systems for hyperbaric chamber technology

TAXIS Pharmaceuticals, Rutgers and UMDNJ to develop and commercialize a novel antimicrobial technology

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Researchers discover new cancer gene that causes adenoid cystic carcinoma

International Stem Cell launches human cell culture products into commercial research markets

As Canadian population ages, blood donors dwindle

Physicians having less than six hours of sleep linked to increase rate of surgical complications

UC Irvine implements automated perioperative solution from Surgical Information Systems

Swedish Risk Drinking Project surveys physicians and nurses of Sweden

NetMotion Wireless publishes free mobile computing white paper for healthcare IT managers

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

New diagnostic technology to detect breast cancer

Research reveals the genetic basis of DispersinB enzyme substrate based biofilm formation in bacteria

Is DDT pesticide safe to combat malaria?

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

NTU condemns Senate Finance Committee's support for health care bill

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

New UCL cancer research centre launched in UK

FDA recommends approval for UI Pharmaceuticals to manufacture an aseptically filled sterile drug product

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News